Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

1
Player Avatar Chemdawg (94.09) Submitted: 9/20/2012 10:13:22 AM : Outperform Start Price: $8.99 ARNA Score: -29.93

this is a possible game changer...obesity and diabetes are in real large supply worldwide and Belviq treats both... without side effects

Featured Broker Partners


Advertisement